• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞性肝内胆汁淤积的换血治疗

Exchange transfusion for sickle cell intrahepatic cholestasis.

作者信息

Sheehy T W, Law D E, Wade B H

出版信息

Arch Intern Med. 1980 Oct;140(10):1364-6.

PMID:7425771
Abstract

Only one of eight previously described patients with sickle cell intrahepatic cholestasis (SCIH) survived. Death usually resulted from liver failure and/or a hemorrhagic diathesis. This report deals with the successful treatment of SCIH by partial blood-plasma exchange transfusion. This treatment led to regression of hepatic encephalopathy, impending bleeding diathesis, and noticeable clinical improvement withn 48 hours. Within six days, the serum bilirubin level decreased from 146 to 16 mg/dL. Partial blood-plasma exchange transfusion may be valuable for the treatment of SCIH.

摘要

先前描述的8例镰状细胞性肝内胆汁淤积症(SCIH)患者中仅有1例存活。死亡通常由肝功能衰竭和/或出血素质导致。本报告论述了通过部分血浆置换输血成功治疗SCIH的病例。该治疗使肝性脑病消退、即将发生的出血素质得到改善,并在48小时内临床症状显著改善。6天内,血清胆红素水平从146mg/dL降至16mg/dL。部分血浆置换输血可能对SCIH的治疗有价值。

相似文献

1
Exchange transfusion for sickle cell intrahepatic cholestasis.镰状细胞性肝内胆汁淤积的换血治疗
Arch Intern Med. 1980 Oct;140(10):1364-6.
2
Can exchange transfusions treat postoperative intrahepatic colestasis in patients with sickle cell anemia?换血疗法能否治疗镰状细胞贫血患者术后肝内胆汁淤积?
Transplant Proc. 2006 Jun;38(5):1385-6. doi: 10.1016/j.transproceed.2006.02.114.
3
Sickle cell intrahepatic cholestasis: approach to a difficult problem.镰状细胞性肝内胆汁淤积症:解决难题的方法
Am J Gastroenterol. 1995 Nov;90(11):2048-50.
4
Sickle cell intrahepatic cholestasis with cholelithiasis.镰状细胞性肝内胆汁淤积伴胆石症
Pediatr Hematol Oncol. 2006 Mar;23(2):95-102. doi: 10.1080/08880010500456964.
5
Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients.镰状细胞性肝病:儿童和成人患者的临床表现、治疗及预后
Pediatr Blood Cancer. 2005 Aug;45(2):184-90. doi: 10.1002/pbc.20317.
6
Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: a case report.长期红细胞置换可成功治疗镰状细胞性肝内胆汁淤积症:一例报告
J Clin Apher. 2004;19(1):17-9. doi: 10.1002/jca.10077.
7
Exchange transfusion for severe intrahepatic cholestasis associated with sickle cell disease?
J Clin Gastroenterol. 2002 Oct;35(4):362-3. doi: 10.1097/00004836-200210000-00019.
8
Rare but Lethal Hepatopathy-Sickle Cell Intrahepatic Cholestasis and Management Strategies.罕见但致命的肝病——镰状细胞性肝内胆汁淤积症及管理策略
Am J Case Rep. 2015 Nov 28;16:840-3. doi: 10.12659/ajcr.895218.
9
Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.红细胞置换输血对急性胸部综合征镰状细胞病患者血浆炎症介质水平的影响。
Am J Hematol. 2004 May;76(1):19-25. doi: 10.1002/ajh.20054.
10
Survival after intrahepatic cholestasis associated with sickle cell disease.镰状细胞病相关肝内胆汁淤积后的生存情况。
J Tenn Med Assoc. 1986 Apr;79(4):199-200.

引用本文的文献

1
Epistaxis: A Rare Presentation of Sickle Cell Intrahepatic Cholestasis.鼻出血:镰状细胞性肝内胆汁淤积症的一种罕见表现。
Case Rep Hematol. 2025 Aug 24;2025:2660044. doi: 10.1155/crh/2660044. eCollection 2025.
2
Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease.镰状细胞病儿童及成人患者的急诊与危重症管理指南
Ann Intensive Care. 2025 May 29;15(1):74. doi: 10.1186/s13613-025-01479-3.
3
Acute Liver Failure With Liver Enzymes >5,000 in Sickle Cell Disease.镰状细胞病中肝酶>5000的急性肝衰竭
ACG Case Rep J. 2024 Mar 20;11(3):e01303. doi: 10.14309/crj.0000000000001303. eCollection 2024 Mar.
4
Management of Sickle Cell Intrahepatic Cholestasis: An Argument in Favor of Automated Exchange Transfusion.镰状细胞性肝内胆汁淤积症的管理:支持自动换血疗法的观点
Clin Hematol Int. 2019 Sep 1;1(3):127-133. doi: 10.2991/chi.d.190630.001. eCollection 2019 Sep.
5
Interventions for treating intrahepatic cholestasis in people with sickle cell disease.镰状细胞病患者肝内胆汁淤积的治疗干预措施。
Cochrane Database Syst Rev. 2020 Jun 22;6(6):CD010985. doi: 10.1002/14651858.CD010985.pub4.
6
N-Acetylcysteine in the Management of Acute Liver Failure From Sickle Cell Hepatic Crisis.N-乙酰半胱氨酸用于镰状细胞性肝危象所致急性肝衰竭的治疗
ACG Case Rep J. 2019 Aug 21;6(8):e00161. doi: 10.14309/crj.0000000000000161. eCollection 2019 Aug.
7
How I treat the older adult with sickle cell disease.我如何治疗老年镰状细胞病患者。
Blood. 2018 Oct 25;132(17):1750-1760. doi: 10.1182/blood-2018-03-818161. Epub 2018 Sep 11.
8
Interventions for treating intrahepatic cholestasis in people with sickle cell disease.镰状细胞病患者肝内胆汁淤积的治疗干预措施。
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD010985. doi: 10.1002/14651858.CD010985.pub3.
9
Rare but Lethal Hepatopathy-Sickle Cell Intrahepatic Cholestasis and Management Strategies.罕见但致命的肝病——镰状细胞性肝内胆汁淤积症及管理策略
Am J Case Rep. 2015 Nov 28;16:840-3. doi: 10.12659/ajcr.895218.
10
Reversal of liver function without exchange transfusion in sickle cell intrahepatic cholestasis.镰状细胞性肝内胆汁淤积症无需换血即可逆转肝功能
Proc (Bayl Univ Med Cent). 2014 Oct;27(4):361-3. doi: 10.1080/08998280.2014.11929160.